Evidence map›Paper›PMID 11477453›Full record

ArticleCancer gene therapy2001

The cytotoxic effect of E1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell lines.

J Zhao, H Wang, L Wei, N A Habib, X Lu, M Wu, Y Guo

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer gene therapy, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

J ZhaoInternational Cancer Institute and Eastern Hospital of Hepatobiliary Surgery, the Second Military Medical University, Shanghai 200433, People's Republic of China.
H Wang
L Wei
N A Habib
X Lu
M Wu
Y Guo
Eastern Hepatobiliary Surgery Hospital · CNHammersmith Hospital · GBLudwig Cancer Research · GBSecond Military Medical University · CNUniversity of Nebraska Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been suggested the E1B 55 kDa mutant adenovirus dl1520 can selectively kill p53-deficient human tumor cells. In this study, we examined the cytotoxic effect of dl1520 on nine human hepatocellular carcinoma (HCC) cell lines with different p53 genetic and functional status. The results showed that HCC cell lines with deleted or mutant p53 gene and reduced p53 transcriptional activities were more susceptible to dl1520-induced cytolysis. Hep3B (p53-null) and HepG2 (p53-wt) cells were arrested at G2/M phase when cytolysis occurred. Cyclin-dependent kinase inhibitor (CDKI) p21(Waf-1/Cip-1) was downregulated 24 hours after dl1520 infection in HepG2 cells and increased when cytolysis occurred. No p21 expression was detected in Hep3B cells. DNA fragmentation was found in both Hep3B and HepG2 cells after dl1520 infection. Bax expression increased in dl1520-infected HepG2 cells but not in Hep3B cells. Notably, three Bax-like proteins, molecular mass around 40 to 80 kDa, accumulated 48 hours after adenovirus infection in Hep3B cells but not in HepG2 cells. These results suggest that the susceptibility of HCC cells to dl1520-induced cytolysis is related to both p53 genotype and functional status, and is mediated by both cell cycle disturbance and apoptosis.

Indexed as

Genetic TherapyMutationProto-Oncogene Proteins c-bcl-2AdenoviridaeAdenovirus E1B ProteinsApoptosisbcl-2-Associated X ProteinBlotting, WesternCarcinoma, HepatocellularCell CycleCell SurvivalCyclin-Dependent Kinase Inhibitor p21CyclinsFlow CytometryGenes, p53HumansAdenovirus E1B ProteinsBAX protein, humanbcl-2-Associated X ProteinCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21CyclinsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2

Identifiers

PMID11477453
OpenAlexW2317014391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.